Grading Ovarian Serous Carcinoma Using a Two-Tier System
By A. Malpica, M. Deavers, K. Lu, D. Bodurka, E. Atkinson, D. Gershenson, Elvio G. Silva. American Journal of Surgical Pathology, 2004
674 citations recorded by the source corpus.
Subfields: Molecular Biology, Public Health, Environmental and Occupational Health, Reproductive Medicine
View Paper: https://www.semanticscholar.org/paper/18361d20da9c292de93e7668a369ab04333bea4e
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
In Public Health, Environmental and Occupational Health
In Reproductive Medicine
Citations in the corpus
- Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features (2012, methodology): “Uniformity of the nuclei is the principal criterion for distinguishing between LGSC and HGSC, with less than threefold variability [25].”
- OVARIAN LOW-GRADE AND HIGH-GRADE SEROUS CARCINOMA: Pathogenesis, Clinicopathologic and Molecular Biologic Features, and Diagnostic Problems (2009, methodology): “In addition, the survival for patients with grades 2 and 3 serous carcinomas using the universal grading system is closer to each other compared with survival for patients with grade 1 and 2 tumors.(10,62) These biologic and clinical findings suggest that moderately and poorly differentiated tumors ”
- Recent Progress in the Diagnosis and Treatment of Ovarian Cancer (2011, background): “Although no universal grading schema exists for ovarian serous carcinoma, a 2-tiered system (low-grade vs high-grade) has received increasing acceptance.(35,36) Histopathologic grade is of prognostic significance(35) and may also be of predictive value in that low-grade tumors appear less responsive”
- Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies (2008, background): “The serous subtype was further subdivided into low- and high-grade [11].”